This CTD dossier owner and manufacturer has been operating for over three decades, focusing on innovative products in the fields of women's health, gynecology, dermatology, and oncology. Their expertise lies in developing novel products using a proprietary technology that leverages natural extraction methods, particularly plant stem cells. This method enhances the delivery and effectiveness of bioactive compounds, leading to improved efficacy in various skin applications, particularly women's health conditions. They manufacture a range of prescription and over-the-counter products, primarily in the form of solids, liquids, and injectables. The company has received EU and USA GMP approvals for its production lines, demonstrating its commitment to quality and safety standards. While specific product patents are not readily available, their commitment to research and innovation suggests a robust patent portfolio.

This CTD dossier owner and manufacturer, established less than a decade ago in the EU region, specializes in producing high-quality dietary supplements. Their product line consists mainly of over-the-counter (OTC) food supplements, with a focus on natural and herbal ingredients. The company prioritizes research and collaboration between medical professionals, ensuring their formulations are effective and target specific health needs. Key therapy areas include cardiovascular health, immune system support, and joint health, although they offer a wide range of other products. The company emphasizes international distribution and has gained a strong reputation in the industry for its commitment to quality and innovation. The company does not explicitly mention EU or US GMP certifications, nor specific product patents. Their products are primarily offered in solid dosage forms, such as capsules and tablets.